Characterization of subtype of α1-adrenoceptor mediating vasoconstriction in perfused rat hind limb

European Journal of Pharmacology

Volumn 329, Issue 1, 1997, Pages 55-61

  Zhu, Weizhong ^a   Zhang, Youyi ^a   Han, Chide ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Hind limb, isolated perfused, rat; (1A) Adrenoceptor

Indexed keywords

2 [2 (4 HYDROXYPHENYL)ETHYLAMINOMETHYL]TETRALONE; 2 [[2 (2,6 DIMETHOXYPHENOXY)ETHYL]AMINOMETHYL] 1,4 BENZODIOXAN; 5 CHLORO N [2 (2 CYCLOPROPYLMETHOXYPHENOXY)ETHYL] ALPHA,ALPHA DIMETHYL 1H INDOLE 3 ETHANAMINE; 5 METHYLURAPIDIL; 8 [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] 8 AZASPIRO[4.5]DECANE 7,9 DIONE; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 1A ADRENERGIC RECEPTOR; ALPHA 1B ADRENERGIC RECEPTOR; ALPHA 1D ADRENERGIC RECEPTOR; CHLOROETHYLCLONIDINE; DESIPRAMINE; INDOMETACIN; IODINE 125; NORADRENALIN; NORMETADRENALIN; PRAZOSIN; PROPRANOLOL; RADIOLIGAND; RECEPTOR SUBTYPE; YOHIMBINE; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; CLONIDINE; DIOXANE DERIVATIVE; DRUG DERIVATIVE; INDOLE DERIVATIVE; PIPERAZINE DERIVATIVE; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; BINDING COMPETITION; CELL LINE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG POTENCY; DRUG SELECTIVITY; EMBRYO; GENETIC TRANSFECTION; HINDLIMB; HUMAN; HUMAN CELL; KIDNEY CELL; LIGAND BINDING; LIMB PERFUSION; MOLECULAR CLONING; NONHUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; REGIONAL PERFUSION; VASOCONSTRICTION; ANIMAL; CLASSIFICATION; DOSE RESPONSE; LIMB; PERFUSION; PHYSIOLOGY;

ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; CELL LINE; CLONIDINE; CLONING, MOLECULAR; DIOXANES; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTREMITIES; HUMANS; INDOLES; NOREPINEPHRINE; PERFUSION; PIPERAZINES; RATS; RECEPTORS, ADRENERGIC, ALPHA-1; RECOMBINANT PROTEINS; VASOCONSTRICTION;

EID: 0031577008     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)10104-2     Document Type: Article

References (34)

1. 1-adrenoceptor subtypes by niguldipine and 5-methyl-urapidil in rat kidney. Br. J. Pharmacol. 102((Suppl.)):1991;196.
2. 1A-adrenoceptors in rat kidney. Br. J. Pharmacol. 107:1992;414-417.
3. 1C-adrenoceptor: studies in the isolated perfused kidney of rat. Br. J. Pharmacol. 115:1995;283-294.
4. 1-adrenoceptors. Eur. J. Pharmacol. 172:1989;131-145.
5. 1D subtype. Eur. J. Pharmacol. 297:1996;241-248.
6. i) and the concentration of inhibitor which causes 50 percent inhibition of an enzymatic reaction. Biochem. Pharmacol. 22:1973;3099-3108.
7. Colquhoun E.Q., Hettiarachchi M., Ye J.M., Rattigen S., Clark M.G. Inhibition by vasodilators of norepinephrine and vasoconstrictor-mediated, but not skeletal muscle contraction-induced oxygen uptake in the perfused rat hindlimb: implications for non-shivering thermogenesis in muscle tissue. Gen. Pharmacol. 21:1990;141-148.
8. 1 adrenoceptor (AR) subtypes in the isolated rat mesenteric vascular bed. FASEB J. 8:1994;A874.
9. 1A-adrenoceptors. Eur. J. Pharmacol. 202:1991;33-44.
10. 1-adrenoceptors. Eur. J. Pharmacol. 73:1981;221-224.
11. 1-Adrenoceptor classification: sharpening Occam's razor. Trends Pharmacol. Sci. 15:1994;167-170.
12. 1-adrenoceptors in human prostate: implications for adrenoceptor classification. Mol. Pharmacol. 49:1996;209-215.
13. 1C-subtype. Mol. Pharmacol. 45:1994;703-708.
14. 2-adrenoceptor involvement in the vascular response to neuronally released and exogenous noradrenaline in the hindlimb of the dog and cat. Eur. J. Pharmacol. 84:1982;189-198.
15. 1-adrenoceptor. Eur. J. Pharmacol. 272:1995;R5-R6.
16. 1-adrenoceptor. Eur. J. Pharmacol. 151:1988;333-335.
17. 2+ in smooth muscle. Nature. 329:1987;333-335.
18. 1-adrenoceptors in rat blood vessels. Eur. J. Pharmacol. 190:1990;97-104.
19. 1-adrenoceptor recognition sites by urapidil derivatives and other selective antagonists. Br. J. Pharmacol. 97:1989;691-700.
20. 1-adrenoceptor subtypes mediating the contraction of human prostatic urethra and peripheral artery. Br. J. Pharmacol. 113:1994;723-728.
21. Karasawa Y., Koss M.C. Distribution of neuronally activated postjunctional adrenoceptors in cat forelimb vasculature. J. Cardiovasc. Pharmacol. 22:1993;594-599.
22. Kenny B.A., Miller A.M., Williams I.J., O'Connell J., Chalmers D.H., Naylor A.M. Evaluation of the pharmacological selective profile of alpha 1 adrenoceptor antagonists at prostatic alpha 1 adrenoceptors: binding, functional and in vivo studies. Br. J. Pharmacol. 118:1996;871-978.
23. Kong J.Q., Taylor D.A., Fleming W.W. Functional distribution and role of alpha-1 adrenoceptor subtypes in the mesenteric vasculature of the rat. J. Pharmacol. Exp. Ther. 268:1994;1153-1159.
24. 1C-) adrenoceptor subtype. Br. J. Pharmacol. 115:1995;781-786.
25. Medgett I.C., Ruffolo R.R. Jr. Alpha-1 adrenoceptor-mediated vasoconstriction in rat hindlimb: innervated alpha-2 adrenoceptors in the saphenous arterial bed. J. Pharmacol. Exp. Ther. 246:1988;249-254.
26. 1-adrenoceptor subtypes. Naunyn-Schmiedeberg's Arch. Pharmacol. 352:1995;1-10.
27. 1-adrenergic receptor subtypes distinguished by chloroethylclonidine and WB 4101. Mol. Pharmacol. 33:1988;509-514.
28. 3H]prazosin binding. Mol. Pharmacol. 29:1986;321-330.
29. 1-receptor binding sites in rat brain. Eur. J. Pharmacol. 109:1985;285-287.
30. 1A adrenoceptor antagonists for the treatment of BPH. Chin. J. Urol. 17:1996;327-329.
31. 1D-adrenergic receptor cDNA. Mol. Pharmacol. 40:1991;876-883.
32. 1-adrenoceptors in vascular smooth muscle. Mol. Pharmacol. 46:1994;30-40.
33. 1-adrenoceptors mediating vasoconstriction to noradrenaline and nerve stimulation in the isolated perfused mesentery of rat. Br. J. Pharmacol. 114:1995;531-536.
34. 1-adrenoceptor subtypes in rat aorta by solution hybridization. Life Sci. 59:1996;343-347.